Add like
Add dislike
Add to saved papers

Diagnosis and follow-up MRI evaluation of tennis leg:New understanding of the pathogenesis and imaging.

Injury 2021 July 5
OBJECTIVES: To evaluate the Magnetic resonance imaging (MRI) findings of patients with a clinical diagnosis of tennis leg and to explore the pathogenesis of tennis leg.

METHODS: A retrospective review of 58 (45 men, 13 women; age range, 7-81 years; mean age, 46.7 years) patients with a clinical diagnosis of tennis leg at our hospital during a 64-month period (May 2014 through Sep 2019) was conducted. All patients underwent MRI scan. Follow-up MRI was performed on 4 patients. Images findings, including integrity of the myotendinous junction and tendon of the gastrocnemius and soleus, and presence of fluid collection were analyzed.

RESULTS: MRI revealed fluid collection between the medial head of the gastrocnemius and soleus in 44 cases (72.1%). In 25 cases (41.0%), the collected fluid spread to around the medial border of fascia cruris. Fifty-five cases (90.2%) had edema or disruption of the gastrocnemius, with most cases (n = 55) showing edema or disruption of the medial head of the gastrocnemius at the myotendinous junction. Twenty-two (36.1%) cases had edema or disruption of the soleus, with most cases (n = 17) showing edema or disruption of the soleus at the myotendinous junction. Plantaris tendon disruption was observed in 7 cases (11.5%). A thick area of reparative tissue at the distal myotendinous junction of the medial head of the gastrocnemius was observed in all 4 MRI patients followed up.

CONCLUSION: Abnormalities of the medial head of the gastrocnemius at the myotendinous junction and tendon appear to be more common than those of the plantaris tendon. Reparative tissue at the distal myotendinous junction of the medial head of the gastrocnemius may be an important specific indication of chronic tennis leg injury.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app